startup.bid
FIL
EnglishEspañolPortuguêsFrançaisDeutschItalianoNederlandsSvenskaDanskNorskPolskiSlovenščinaTürkçeРусскийBahasa IndonesiaBahasa MelayuFilipinoTiếng ViệtKiswahiliहिन्दीاردوالعربيةעברית日本語한국어中文繁體中文

zPREDICTA

Patient-derived 3D tissue reconstruction models for preclinical…

Na-acquire

Tungkol sa kumpanya

Paglalarawan ng kumpanya sa Ingles

zPREDICTA is developing organ-specific, physiologically-relevant 3D cell culture models providing a 1-to-1 reconstruction of human tissues. This is the only available 3D culture approach that comprehensively accounts for the major components of the cellular and extracellular tissue microenvironment preserving the critical interactions between a tumor and its surroundings. Clinical study data demonstrate the high correlation between drug efficacy measured in our platform and the clinical response. The ability of the zPREDICTA platform to reliably predict clinical outcomes offers superior compound attrition management, empowering researchers to exclude ineffective compounds while selecting agents with a high probability of success in the clinic.

Our approach is compatible with any drug class, multiple tissue/cell types and a wide variety of readouts. Our customers are using these models for efficacy screening of anticancer compounds, including immuno-oncology agents, evaluation of mechanisms of drug resistance, the rescue of failed drug candidates, assessment of off-target toxicity, and a multitude other applications.

Mga paksa

Lokasyon
San Francisco, CA, Estados Unidos
Laki ng team
2 empleyado
Batch sa YC
Summer 2015
Status
Na-acquire
Yugto
Maagang yugto

Mga katulad na startup at kakumpitensya

Mga tanong at sagot

Saan nakabase ang zPREDICTA?

San Francisco, CA, Estados Unidos

Ilan ang empleyado ng zPREDICTA?

2 empleyado, ayon sa profile ng kumpanya.

Nakalikom na ba ng pondo ang zPREDICTA?

Walang funding round ang zPREDICTA sa aming datos.

Ano ang mga alternatibo sa zPREDICTA?

Mga katulad na startup: Numerion Labs, Verge Genomics, at PostEra.